Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

NCT06660134 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)
Atrial Fibrillation (AF)

Interventions

DRUG: Glucagon-like peptide-1 receptor agonists (GLP 1 RA)

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]
[object Object]
[object Object]